Back to User profile » Dr Cecilia Lazea

Papers published by Dr Cecilia Lazea:

PFAPA Syndrome: Clinical, Laboratory and Therapeutic Features in a Single-Centre Cohort

Lazea C, Damian L, Vulturar R, Lazar C

International Journal of General Medicine 2022, 15:6871-6880

Published Date: 29 August 2022

Diagnosis and Management of Genetic Causes of Middle Aortic Syndrome in Children: A Comprehensive Literature Review

Lazea C, Al-Khzouz C, Sufana C, Miclea D, Asavoaie C, Filimon I, Fufezan O

Therapeutics and Clinical Risk Management 2022, 18:233-248

Published Date: 16 March 2022

Diagnostic Usefulness of MLPA Techniques for Recurrent Copy Number Variants Detection in Global Developmental Delay/Intellectual Disability

Miclea D, Szucs A, Mirea AM, Stefan DM, Nazarie F, Bucerzan S, Lazea C, Grama A, Pop TL, Farcas M, Zaharie G, Matyas M, Mager Snr M, Vintan M, Popp R, Alkhzouz C

International Journal of General Medicine 2021, 14:4511-4515

Published Date: 16 August 2021

Skeletal Abnormalities and VDR1 Gene Polymorphisms in Mucopolysaccharidosis Patients

Alkhzouz C, Cabau G, Lazea C, Asavoaie C, Bucerzan S, Mirea AM, Farcas M, Miclaus M Jnr, Popp R, Miclea D

Pharmacogenomics and Personalized Medicine 2021, 14:349-358

Published Date: 17 March 2021

Unusual Presentation Of Kawasaki Disease With Gastrointestinal And Renal Manifestations

Lazea C, Man O, Sur LM, Serban R, Lazar C

Therapeutics and Clinical Risk Management 2019, 15:1411-1416

Published Date: 5 December 2019

Rare complications of neurofibromatosis 1 diagnosed incidentally in two children

Lazea C, Asavoaie C, Al-Khzouz C, Popa L

Therapeutics and Clinical Risk Management 2018, 14:1547-1552

Published Date: 31 August 2018

Clinical and genetic characteristics in a group of 45 patients with Turner syndrome (monocentric study)

Bucerzan S, Miclea D, Popp R, Alkhzouz C, Lazea C, Pop IV, Grigorescu-Sido P

Therapeutics and Clinical Risk Management 2017, 13:613-622

Published Date: 4 May 2017